Application of causal inference methods in the analyses of randomised controlled trials: a systematic review

被引:20
作者
Farmer, Ruth E. [1 ,2 ]
Kounali, Daphne [3 ]
Walker, A. Sarah [1 ]
Savovic, Jelena [3 ,4 ]
Richards, Alison [3 ,4 ]
May, Margaret T. [3 ]
Ford, Deborah [1 ]
机构
[1] UCL, MRC Clin Trials Unit, Inst Clin Trials & Methodol, Sch Life & Med Sci, London, England
[2] London Sch Hyg & Trop Med, Dept Noncommun Dis Epidemiol, London, England
[3] Univ Bristol, Bristol Med Sch, Bristol, Avon, England
[4] Univ Hosp Bristol NHS Fdn Trust, NIHR CLAHRC West, Bristol, Avon, England
基金
英国医学研究理事会;
关键词
Causal inference; RCT; Systematic review; Time-dependent confounding; Marginal structural models; Marginal nested models; G-computation; G-estimation; MARGINAL STRUCTURAL MODELS; FAILURE TIME MODELS; ANTIRETROVIRAL THERAPY; INVERSE PROBABILITY; HIV ACQUISITION; CLINICAL-TRIAL; PROPHYLAXIS THERAPY; TREATMENT REGIMES; BIPOLAR I; AIDS;
D O I
10.1186/s13063-017-2381-x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Applications of causal inference methods to randomised controlled trial (RCT) data have usually focused on adjusting for compliance with the randomised intervention rather than on using RCT data to address other, non-randomised questions. In this paper we review use of causal inference methods to assess the impact of aspects of patient management other than the randomised intervention in RCTs. Methods: We identified papers that used causal inference methodology in RCT data from Medline, Premedline, Embase, Cochrane Library, and Web of Science from 1986 to September 2014, using a forward citation search of five seminal papers, and a keyword search. We did not include studies where inverse probability weighting was used solely to balance baseline characteristics, adjust for loss to follow-up or adjust for non-compliance to randomised treatment. Studies where the exposure could not be assigned were also excluded. Results: There were 25 papers identified. Nearly half the papers (11/25) estimated the causal effect of concomitant medication on outcome. The remainder were concerned with post-randomisation treatment regimens (sequential treatments, n = 5), effects of treatment timing (n = 2) and treatment dosing or duration (n = 7). Examples were found in cardiovascular disease (n = 5), HIV (n = 7), cancer (n = 6), mental health (n = 4), paediatrics (n = 2) and transfusion medicine (n = 1). The most common method implemented was a marginal structural model with inverse probability of treatment weighting. Conclusions: Examples of studies which exploit RCT data to address non-randomised questions using causal inference methodology remain relatively limited, despite the growth in methodological development and increasing utilisation in observational studies. Further efforts may be needed to promote use of causal methods to address additional clinical questions within RCTs to maximise their value.
引用
收藏
页数:14
相关论文
共 60 条
  • [11] The Impact of Different CD4 Cell-Count Monitoring and Switching Strategies on Mortality in HIV-Infected African Adults on Antiretroviral Therapy: An Application of Dynamic Marginal Structural Models
    Ford, Deborah
    Robins, James M.
    Petersen, Maya L.
    Gibb, Diana M.
    Gilks, Charles F.
    Mugyenyi, Peter
    Grosskurth, Heiner
    Hakim, James
    Katabira, Elly
    Babiker, Abdel G.
    Walker, A. Sarah
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2015, 182 (07) : 633 - 643
  • [12] Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men
    Hernán, MA
    Brumback, B
    Robins, JM
    [J]. EPIDEMIOLOGY, 2000, 11 (05) : 561 - 570
  • [13] Structural accelerated failure time models for survival analysis in studies with time-varying treatments
    Hernán, MA
    Cole, SR
    Margolick, J
    Cohen, M
    Robins, JM
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2005, 14 (07) : 477 - 491
  • [14] Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures
    Hernán, MA
    Brumback, BA
    Robins, JM
    [J]. STATISTICS IN MEDICINE, 2002, 21 (12) : 1689 - 1709
  • [15] Marginal structural models to estimate the joint causal effect of nonrandomized treatments
    Hernán, MA
    Brumback, B
    Robins, JM
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 2001, 96 (454) : 440 - 448
  • [16] Observational Studies Analyzed Like Randomized Experiments An Application to Postmenopausal Hormone Therapy and Coronary Heart Disease
    Hernan, Miguel A.
    Alonso, Alvaro
    Logan, Roger
    Grodstein, Francine
    Michels, Karin B.
    Willett, Walter C.
    Manson, JoAnn E.
    Robins, James M.
    [J]. EPIDEMIOLOGY, 2008, 19 (06) : 766 - 779
  • [17] Renin-angiotensin system blockade and kidney transplantation: a longitudinal cohort study
    Hernandez, Domingo
    Muriel, Alfonso
    Abraira, Ctor
    Perez, German
    Porrini, Esteban
    Marrero, Domingo
    Zamora, Javier
    Manuel Gonzalez-Posada, Jose
    Delgado, Patricia
    Rufino, Margarita
    Torres, Armando
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (01) : 417 - 422
  • [18] Effects of Voglibose and Nateglinide on Glycemic Status and Coronary Atherosclerosis in Early-Stage Diabetic Patients
    Kataoka, Yu
    Yasuda, Satoshi
    Miyamoto, Yoshihiro
    Sase, Kazuhiro
    Kosuge, Masami
    Kimura, Kazuo
    Yoshimasa, Yasunao
    Miyazaki, Shunichi
    [J]. CIRCULATION JOURNAL, 2012, 76 (03) : 712 - 720
  • [19] Evaluating the Effect of Early Versus Late ARV Regimen Change if Failure on an Initial Regimen: Results From the AIDS Clinical Trials Group Study A5095
    Li, Li
    Eron, Joseph J.
    Ribaudo, Heather
    Gulick, Roy M.
    Johnson, Brent A.
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 2012, 107 (498) : 542 - 554
  • [20] Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2700, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007, 10.1016/j.ijsu.2010.07.299]